Recursion
Salt Lake City, US Β· Founded 2013 Β· 14 known investors
Recursion applies artificial intelligence and large-scale data analysis to accelerate drug discovery and development. The company develops therapeutics for patients waiting for new treatment options by industrializing pharmaceutical research through automation and computational biology.
AI & Machine LearningBiotechDeep TechMedical Devices
Founders & leadership
Recursion was founded in 2013 by Chris Gibson.
CG
Chris GibsonCo-founder, Chairman of the Board
Investors Β· 14
DCVC (Data Collective)β verifiedPalo Alto Β· $5M β $25M
Lux Capitalβ verifiedNew York Β· $100K β $100M
Baillie Giffordβ verifiedEdinburgh
Air Street CapitalSt. Peter Port Β· $500K β $10M
Amplify PartnersMenlo Park Β· $500K β $5M
Catalio Capital Management, LPNew York
Central Texas Angel NetworkAustin
EPIC VENTURESSalt Lake City
KinnevikStockholm
Obvious VenturesSan Francisco Β· $250K β $6M
Transform Capital ManagementSan Francisco
Village GlobalCovina Β· $100K β $500K
Novo HoldingsreportedCopenhagen Β· $1.1M β $54M
NVIDIAreportedSanta Clara
Non-dilutive funding Β· 5 SBIR/STTR awards
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $223K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $224.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $217.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Recursion do?
- Recursion applies artificial intelligence and large-scale data analysis to accelerate drug discovery and development. The company develops therapeutics for patients waiting for new treatment options by industrializing pharmaceutical research through automation and computational biology.
- Who founded Recursion?
- Recursion was founded by Chris Gibson in 2013.
- Who are Recursion's investors?
- Recursion's investors include DCVC (Data Collective), Lux Capital, Baillie Gifford, Air Street Capital, Amplify Partners, Catalio Capital Management, LP, Central Texas Angel Network, EPIC VENTURES and 6 more.
- Where is Recursion headquartered?
- Recursion is headquartered in Salt Lake City, US.